An indirect enzyme-linked immunosorbent assay (ELISA) was developed at the National Veterinary Institute (NVI), Uppsala, to detect antibodies to bovine respiratory syncytial virus (BRSV) in serum and milk. For the evaluation of the NVI ELISA, field sera collected from cattle in England and Sweden were tested in parallel with an ELISA in use at the Central Veterinary Laboratory (CVL), Weybridge. The tests showed 96% agreement. The sensitivity and specificity of the NVI ELISA relative to the CVL ELISA were 94% and 100%, respectively. There was evidence that the difference in sensitivity between the 2 tests was due to the detection of both IgG and IgM class antibodies by the CVL ELISA, whereas the NVI ELISA was designed specifically to detect IgGl. Milk and serum samples from individual cows were tested by the NVI ELISA for presence of antibodies to BRSV. There was a good correlation between the ability to detect antibodies in serum and the ability to detect them in milk, although the antibody titer was generally lower in milk than in serum. Bulk milk samples were collected from farms with severe clinical symptoms of respiratory distress and from farms with no history of respiratory disease. There was a clear distinction between antibody levels in diseased and healthy herds. The NVI ELISA is a rapid and reliable test for detecting antibodies to BRSV in milk, bulk milk, and serum samples.
Bovine respiratory syncytial virus (BRSV) is one of the most important causes of respiratory disease in beef and dairy cattle. 22, 23 The virus was first isolated in Switzerland in 1967 19 and was subsequently isolated in Belgium, 26 Great Britain 9 Japan 8 and the United States. 1 Epizootics of acute respiratory disease associated with BRSV have since been reported from many countries. 12, 21 Severe outbreaks of respiratory disease, caused by BRSV, occur every year in dairy herds in different regions of Sweden. 3, 10 Most cases are recorded during the winter months (November-February) in accordance with data from international literature; but in contrast to most reports it is not young calves but lactating cows that are most seriously affected. Fever, coughing, respiratory distress, and a marked drop in milk production are the main symptoms. The morbidity rate is high in a majority of diseased herds, whereas the mortality rate in some herds with confirmed acute infection has varied between 5% and 20%. In exceptional cases, the mortality rate has been even higher.
Serologic methods currently in use for detecting antibodies to BRSV are the serum neutralization (SN) test, the complement fixation test, the indirect fluorescent antibody test, and the enzyme-linked immunosorbent assay (ELISA). 2, 5, 7, 14, 20, 24, 27 In the winter of 1988/1989, the number of dairy herds severely affected by respiratory disease increased in Sweden. The recent development of a new indirect ELISA for detection of BRSV IgGl antibodies in serum and milk was of a great help in the diagnosis. In this paper, we report on the evaluation of this indirect ELISA for detection of antibodies to BRSV in serum and milk and a comparison of this assay with an established ELISA for BRSV antibody detection in serum used for 10 years at the Central Veterinary Laboratory (CVL), Weybridge, England.
Materials and methods
Serum samples. Field sera collected from cattle in England and Sweden were tested in parallel by ELISA at the CVL, Weybridge, and the National Veterinary Institute (NVI), Uppsala. The 174 sera were selected from material received for diagnostic purposes. Eighty-eight of the samples came from English herds, and 86 came from Swedish herds. The results of the 2 ELISAs were compared, and specificity and sensitivity were calculated. 17 In addition to the 174 sera, paired acute and convalescent sera from 10 animals in Swedish herds with confirmed BRSV infection were tested for IgG antibodies in the 2 ELISA systems. Those sera had earlier been analyzed for IgM antibodies using an IgM capture ELISA. 6 Individual milk and serum samples from dairy cows. Individual milk and serum samples were collected from 48 Swedish dairy cows. Twenty-three of the sampled animals came from a herd tested BRSV negative on bulk milk and with no history of respiratory disease. The remaining 25 samples came from 3 different herds with a known history of BRSV infection. Sera from the BRSV-negative herd were also tested in parallel at the CVL.
All individual and bulk milk samples were collected in 10ml plastic tubes. Fat was removed from all milk samples after centrifugation at 3,000 rpm for 10 min and stored at -20 C until analyzed.
Bulk milk samples from herds with and without respiratory disease. Bulk milk samples were collected from 21 dairy herds with severe clinical symptoms of respiratory disease and from 15 apparently healthy dairy herds located in the northern part of Sweden. The samples were collected with the assistance of local veterinarians during the winter months of 1989 when BRSV was not yet widely spread in this part of Sweden. The veterinarians had been instructed to select farms with definite symptoms of respiratory distress and farms without any history of respiratory disease.
Diagnostic samples collected in 2 dairy herds with acute BRSV infection. Blood samples and nasal swabs were collected in southeastern Sweden from 21 animals in 2 neighboring dairy herds with acute and very severe outbreaks of respiratory disease. Bulk milk samples were also collected. Blood and bulk milk samples were collected from the same animals 2 and 4 wk later.
Virus and cell culture. BRSV strain RB94 25 was propagated in primary bovine turbinate (BT) cells. The virus inoculum was absorbed to a confluent layer of BT cells for 1 hr at 37 C. The cells were maintained with Eagle's minimum essential medium (EMEM) supplemented with 2% fetal calf serum. Mock-infected cells were grown in parallel for preparation of control antigen. The cells were incubated at 37 C, harvested when showing 90-100% cytopathic effect (CPE), frozen at -70 C, and thawed once before preparation of antigen.
Preparation of BRSV antigens for the NVI ELISA. The BRSV antigen and the control antigen cells were centrifuged separately in an ultracentrifuge, using the TFA-20 rotor for 18 hr at 100,000 x g. The pellets were dissolved in 0.05 M sodium carbonate buffer (pH 9.6), sonicated for 30 sec, and clarified by low-speed centrifugation. The antigen was aliquoted and stored at -70 C until used.
Preparation and conjugation of an anti-bovine IgG monoclonal antibody for the NVI ELISA. The method was performed as previously described. 11, 15 NVI ELISA procedure. One hundred microliters of the BRSV and control antigen, in an appropriate dilution ranging between 1:100 and 1:1,000 in 0.05 M sodium carbonate buffer (pH 9.6) containing 0.05% NaN 3 , were dispensed into each well in parallel rows of 96-well microtiter plates a and incubated overnight (> 16 hr) at 4 C. The plates were rinsed before use. Serum samples were either tested in a single dilution of 1:100 or assayed in 5-fold dilution in phosphatebuffered saline (PBS) containing 0.2% Tween 20 (PBS-T). Defatted milk samples were tested undiluted. One hundred microliters of the test sample was added to each of 2 wells coated with antigen and in similar manner to duplicate wells coated with control antigen. According to the recommendations by the Joint FAO/IAEA Division, a strong positive, a weak positive, and a negative control were run as standards in duplicate wells on each ELISA plate. The plates were sealed and incubated for 1 hr at 37 C. After each incubation step in the ELISA procedure, nonbound material was removed after washing 3 times in PBS-T. One hundred microliters of the conjugate diluted in PBS-T was added to all wells, and the plates were sealed and incubated for 1 hr at 37 C. After washing, 200 µ1 of freshly prepared TMB substrate (0.1 mg/ ml tetramethylbenzidine dissolved in dimethylsulfoxide in 0.1 M sodium acetate buffer [pH 6.01 containing 0.04 µ1 of 30% H 2 O 2 ) was added to each well. After 10 min at room temperature, 50 µ1 of 2 M H 2 SO 4 was added to stop the reaction. The optical density (OD) was measured at 450 nm on a dual-beam microtiter plate reader. The mean OD value for paired wells was calculated. The mean OD value for the control antigen was subtracted from the corresponding antigen OD value (=corrected OD value). Serum samples were considered positive if their OD value was above 0.1 (0.1 = mean OD 450 + 3 SD for 46 sera from BRSV-free dairy cows negative for serum neutralizing antibodies to BRSV). Milk samples were considered positive if their OD value was above 0.04 (0.04 = mean OD 450 + 3 SD for 46 individual milk samples from the same BRSV-free dairy cows as above). Whenever titration was performed, the titers were estimated as the highest dilution given an OD value above 0.1 for serum and 0.04 for milk. Individual serum and milk samples were run in duplicate wells. Negative and positive milk samples were titrated in negative milk in 2-fold dilutions and compared with a corresponding serum titration.
Definition ofpositive standards in NVI ELISA. Dairy cows with a history of an acute outbreak of BRSV infection were used for positive controls. Pooled sera with serum neutralizing antibodies (at least 1:64 end point titer) were selected according to the recommendations of the FAO/IAEA Division (Report of a joint FAO/IAEA Consultants Meeting on ELISA Data Evaluation and Expression, January [27] [28] [29] [30] [31] 1992) .
Definition of negative standards in NVI ELISA. Pooled sera from cows in 2 dairy herds that tested negative for serum neutralization antibodies to BRSV (titer < 1:2) were used as negative controls in accordance to the FAO/IAEA recommendations. The herds had no history of BRSV-associated respiratory disease.
CVL ELISA procedure. BRSV strain RB94 was grown in secondary bovine kidney cells. When extensive CPE was present, affecting 90-100% of the cells, any remaining adherent cells were scraped from the culture vessel into the medium, and the cells pelleted by centrifuging at 2,000 x g for 10 min. The pellet was resuspended in a small volume (1 ml/180.cm 2 flask) of 0.5% Nonidet P40 in PBS and left for 1 hr at 4 C. The cell debris was removed by centrifugation at 2,000 x g for 20 min, and the supernatant was used as antigen. Control antigen was prepared in parallel from noninfected cells. The antigens were lyophilized in small aliquots. The optimal coating dilution of antigen was determined by titration using known positive and negative sera. Positive and control antigens were diluted in 0.05 M carbonate buffer (pH 9.6) and coated overnight at 4 C onto alternate rows of flexible 96-well microtiter plates. The plates were washed and stored at 4 C. Test sera were diluted 1:100 in PBS-T with 1% polyvinylpyrrolidone before addition of 50 µl to each of 4 wells (2 BRSV antigen and 2 control antigen). The plates were incubated for 2 hr at room temperature and then washed 3 times in PBS-T. Rabbit anti-bovine immunoglobulin peroxidase conjugate b was added at a predetermined dilution in PBS-T for 1 hr at room temperature. After a further wash, TMB substrate was added as described above, the reaction was stopped after 10 min, and the OD was read at 450 nm. The result for each sample was calculated as mean OD (BRSV antigen) -mean OD (control antigen). Values below 0.10 were considered negative, 0.10-0.20 were in the "gray zone," and >0.20 were positive, based on previous evaluation of the test with known positive and negative sera (S. Edwards, unpublished data). The CVL indirect ELISA was used for testing serum samples but not for milk samples, in parallel with the NVI indirect ELISA.
Immunofluorescence method. A commercially available bovine antibody to BRSV conjugated to fluorescein isothiocyanate was used. c The BRSV antigen was detected by direct immunofluorescence as follows. Nasal swabs were soaked with 200 µl 0.01 M PBS (pH 7.6) for 30 min in a small tube. After soaking, the tube was punctured and put into a tube one size larger and centrifuged at 14,000 rpm for 10 sec in an Eppendorf centrifuge. The cell pellet was resuspended in 50 µl PBS and placed on a glass slide. The slides were air dried and fixed for 10 min in cold acetone. After washing for 10 min in PBS, the conjugate, properly diluted, was applied and the slides were incubated for 30 min in a humid chamber at 37 C. The slides were washed in PBS 3 times for 5 min each, mounted in PBS/glycerol, and examined with a fluorescence microscope.
Serum neutralization test. A microtiter SN test, similar to a previously described method, was used. 1 Two-fold dilutions of sera (100 µl, inactivated at 56 C for 30 min) were mixed with 100 µl of a virus suspension (strain RB94) containing approximately 100 TCID 50 /0.1 ml and incubated at 37 C for 60 min. One hundred microliters of each mixture was inoculated onto a monolayer of BT cells in 96-well microplates (4 wells/sample) and adsorbed for 1 hr at 37 C. One hundred microliters of EMEM supplemented with 2% fetal calf serum was added to each well. The plates were incubated for 4-5 days at 37 C in a 5% CO 2 humidified atmosphere. The highest dilution of serum inhibiting CPE was taken as the end point titer.
ELISA procedure for detection of antibodies to other bovine viruses. Commercial tests for the detection of bovine viral diarrhea virus (BVDV), bovine coronavirus (BCV), and Parainfluenza-3 virus (PIV-3) were used in accordance with the manufacturers recommendations. d Statistical analysis. The analytical error of the method was calculated from the formula where n is the number of duplicate determinations and d is the difference in a certain pair. 
Results
Comparison between the NVI ELISA and the CVL ELISA. One hundred seventy-four serum samples were run in parallel at the CVL and at the NVI. In the comparison between the 2 ELISA systems, 93 sera scored positive and 58 sera scored negative in both tests. Excluded from the comparison were 17 sera with an absorbance value between 0.1 and 0.2 in the CVL ELISA and therefore considered to be in the "gray zone" according to the CVL ELISA standards. All these 17 sera were negative in the NVI ELISA.
The results of the NVI ELISA and the CVL ELISA were compared for 157 serum samples that scored either positive or negative. The tests showed 96% agreement. The sensitivity and specificity of the NVI ELISA relative to the CVL ELISA were 94% and 100%, respectively ( Table 1 ). All 58 samples negative in the CVL ELISA were also negative in the NVI ELISA. However, 6 samples that scored positive in the CVL ELISA (absorbance values: 0.20, 0.21, 0.30, 0.37, 0.33, 0.21) were negative in the NVI ELISA.
Ten acute and 10 convalescent sera from animals with clinically confirmed BRSV infection showed a total agreement of positive samples for the 10 convalescent sera. In the acute sera, 1 sample scored positive by the NVI ELISA, whereas this sample and 4 others scored positive by the CVL ELISA. When tested for presence of IgM antibodies with an IgM ELISA, there was a good correlation between acute sera scored as positive or in the "gray zone" in the CVL ELISA and the presence of IgM antibodies. The acute sera tested by the NVI ELISA did not correlate with the IgM titer (Table 2) .
Correlation between antibody titers in individual serum and milk samples. Serum antibodies to BRSV were detected in 25 of the 48 cows examined. Twentythree of the 25 cows with antibodies to BRSV in their sera were also positive for BRSV antibodies in milk. The 2 cows with no antibodies in milk had very low antibody titers in their sera. The antibody titer was lower in the milk than in the serum in all cows tested (Fig. 1) . Serum antibodies were not detected in 23 cows, and those animals were also negative for antibodies in milk.
Bulk milk samples. The level of antibodies to BRSV in bulk milk samples from 21 herds with a history of respiratory disease showed an absorbance value of 0.94 ± SD). Bulk milk samples from unaffected healthy herds, in all 15, showed an absorbance value of 0.02 ± 0.03.
Blood, milk, and nasal swab samples from animals with acute BRSV infection. BRSV was detected by immunofluorescence in nasal swabs from 8 of the 21 sampled animals at the first farm visit. Bulk milk was collected from both farms, and individual sera were collected from diseased animals. The first bulk milk samples showed a low OD value in both herds, 0.09 and 0.17. The first individual serum samples scored negative for 16 animals and the rest were low positives. Paired serum and bulk milk samples were collected 2 weeks later. There was a significant increase in titers (at minimum 2 titration steps) in all the sampled animals as well as an increase of the OD value in the bulk milk. At a third visit, 4 weeks later, samples were collected from the same animals and from the bulk milk. The antibody levels had increased further in the 10 animals and in the bulk milk samples ( Table 3 ). All samples were analyzed for antibodies to BVDV, BCV, and PIV-3. Two sera were positive for BVDV, all of them were positive for BCV, and all but 5 were positive for PIV-3, but there was no evidence of active sero- conversion to these viruses between acute and convalescent sera.
Analytical error of the NVI ELISA. The analytical error of the NVI ELISA, expressed as a percentage of mean absorbance value, was calculated from 88 duplicate serum samples and 88 duplicate milk samples and was 8% for serum and 6% for skim milk.
Discussion
The results obtained in the comparison between the NVI ELISA and the CVL ELISA showed 100% specificity, i.e., a total agreement of negative samples ( Table  1 ). The sensitivitv was 94% because of 6 samples that Table 3 . Blood and milk samples were analyzed on 3 different days* for the presence of antibodies to bovine respiratory syncytial virus (BRSV) from animals with an acute BRSV infection. Nasal swabs were analyzed for the presence of BRSV by immunofluorescence (IF).
were positive in the CVL ELISA but negative in the NVI ELISA. The absorbance values for these sera indicated that they were low positives (0.20-0.37). A possible explanation for the discrepancy in results for 6 samples is that the CVL ELISA conjugate is a commercial rabbit anti-bovine immunoglobulin that reacts with IgM antibodies as well as IgG antibodies in sera taken early in the infection. In the 10 acute and convalescent sera from cows with a confirmed BRSV infection, 5 acute sera positive for BRSV antibodies in the CVL ELISA were also positive for IgM antibodies in the IgM ELISA. This correlation was not seen for the NVI ELISA ( Table 2 ). Two of the 5 acute sera that were negative in the CVL ELISA were also negative in the IgM ELISA. The discrepant results for the remaining 3 sera, considered to be in the "gray zone" in the CVL ELISA, could have been due to either analytical error or the presence of virus-specific IgM antibodies ( Table 2) . Following an experimental infection with wild type strains of BRSV, an IgGl response was found 10-16 days postinoculation (PI). 6 IgM titers were first detected on day 10 PI, reached a maximum on day 16 PI, and then decreased rapidly to be undetectable on day 38 PI. In a similar experiment, it was shown that colostrum-deprived calves had a detectable level of IgM antibodies at 8-10 days PI, whereas IgGl antibodies were detected at 13-17 days PI. 13 In both experiments, IgGl and IgM titers were detectable at about the same time. The IgGl titer was very low for the first week, whereas the IgM titer was rapidly increasing.
In the comparison of the 2 ELISA systems, only samples that scored either positive or negative were used in the calculation. 17 Of the 174 samples tested, 17 sera were considered to be in the "gray zone" by the CVL ELISA standards. These "gray zone" absorbance values in the CVL ELISA could be due to the presence of IgM antibodies. Unfortunately, the 17 sera could not be tested for IgM antibodies because the IgM ELISA was no longer available. All of those 17 sera scored negative in the NVI ELISA.
The NVI indirect ELISA, which applies a monoclonal antibody to bovine IgGl, seems to be very specific in detecting only IgGl antibodies, providing a reliable method for distinguishing between acute and convalescent titers ( Table 2 ). The use of a monoclonal antibovine IgGl in the ELISA makes this assay useful for the milk as well as for serum. 18 The application of the assay to milk samples was validated by the fact that 23 of the 25 cows with antibodies to BRSV in their serum also had antibodies in their milk. The remaining 2 cows, which were negative in their milk, had very low antibody titers in their sera. The level of antibodies in milk is in general lower than that in serum, which may be why the two low-positive sera were negative in the milk samples 4, 16 (Fig. 1) . No seronegative cow was positive for BRSV antibodies in milk.
The method of analyzing bulk milk for detection of antibodies to BRSV was very useful when the majority of herds in the northern part of Sweden were still uninfected. By sampling bulk milk from herds with clinical symptoms of BRSV infection and from herds with no history of severe respiratory disease it was at that time possible to see a clear distinction between antibody levels in diseased and healthy herds. In recent years, we have analyzed a large number of bulk milk samples from herds that are antibody positive or that have seroconverted without showing distinct symptoms of BRSV infection. A possible explanation for asymptomatic seroconversion is a difference in virulence among BRSV strains. The method of analyzing bulk milk is still in use to exclude BRSV infection as the cause of disease outbreaks in a single herd or in a particular area of the country. By sampling bulk milk twice, in the acute and convalescent stage of disease, the diagnosis of BRSV infection at the herd level could be confirmed (Table 3) . At present, BRSV is an established pathogen within the Swedish cattle population. The frequency of outbreaks of respiratory disease is not as high as during 1989/1990, but there are still a number of herds with severe BRSV infection every year, resulting in reduced milk production and sporadic deaths among the cows (M. Elvander, in manuscript).
The indirect BRSV NVI ELISA is a rapid and reliable method for detecting antibodies to BRSV in milk, bulk milk, and serum samples.
